The Patent Finder
AD

Abbott Diabetes Care Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

889 patents currently held

10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Nov 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
379
Ending by 2030
Nov 2026
Next term end
310
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Closed Loop Control And Signal Attenuation Detection US 9,392,969
Cited by 469 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2029.
Ends Dec 2029 · High confidence
Also notable
Flexible Patch for Fluid Delivery and Monitoring Body Analytes US 9,259,175
Cited by 318 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Ends Sep 2032 · High confidence
Also notable
Analyte Sensor and Apparatus for Insertion of the Sensor US 9,402,544
Cited by 455 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Ends Apr 2032 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 8 fees due Jan 9 to 25, 2027 · next Jan 9
  • 12 fees due Feb 4 to 28, 2027 · next Feb 4
  • 8 fees due Mar 3 to 26, 2027 · next Mar 3
  • 9 fees due Apr 1 to 29, 2027 · next Apr 1
  • 10 fees due May 3 to 17, 2027 · next May 3
  • 9 fees due Jun 3 to 26, 2027 · next Jun 3
  • 5 fees due Jul 5 to 16, 2027 · next Jul 5
  • 4 fees due Aug 13 to 23, 2027 · next Aug 13
  • 8 fees due Sep 1 to 24, 2027 · next Sep 1
  • 17 fees due Oct 9 to 28, 2027 · next Oct 9
  • 2 fees due Nov 3 to 10, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The largest of its 310 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,220,145Integrated Analyte Sensor and Infusion Device and Methods Therefor
In force
 · High confidence
In forceHigh confidence
US 8,374,925Method and System for Monitoring Consumable Item Usage and Providing Replenishment Thereof
In force
 · High confidence
In forceHigh confidence
US 8,116,840Method of Calibrating of an Analyte-Measurement Device, and Associated Methods, Devices and Systems
In force
 · High confidence
In forceHigh confidence
US 9,097,660Analyte Sensors and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 9,465,005Analyte Sensors and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 9,364,149Analyte Sensor Transmitter Unit Configuration for a Data Monitoring and Management System
In force
 · Low confidence
In forceLow confidence
US 10,206,629Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management
In force
 · High confidence
In forceHigh confidence
US 9,625,411Methods of making a test sensor
In force
 · High confidence
In forceHigh confidence
US 8,677,611Methods of Making Calibration-Adjusted Sensors
In force
 · High confidence
In forceHigh confidence
US 8,718,943Method and device for utilizing analyte levels to assist in the treatment of diabetes
In force
 · High confidence
In forceHigh confidence
10 of 889 patents shown.
Pro members see all 889.
Pro members: see all 889 patents
Also on record, not counted in the 889: 10 patents in force now held by others · 584 patents ended · 272 applications pending · 489 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited